Adherence to Medications Susan E. Fleming, MN, RN Michele Wolfe, MN, ARNP Cindy Corbett, PhD, RN.
33
Adherence to Medications Susan E. Fleming, MN, RN Michele Wolfe, MN, ARNP Cindy Corbett, PhD, RN
-
Upload
angela-obrien -
Category
Documents
-
view
214 -
download
0
Transcript of Adherence to Medications Susan E. Fleming, MN, RN Michele Wolfe, MN, ARNP Cindy Corbett, PhD, RN.
Adherence to MedicationsSusan E. Fleming, MN, RNMichele Wolfe, MN, ARNP Cindy Corbett, PhD, RN
Susan E. Fleming, MN,
RN
Michele Wolfe, MN,
ARNP
Cindy Corbett, PhD, RN
Learning Objectives
o Describe adherence & co-morbidity
o Identify WHO’s Five Dimensions to Medication Adherence
o Describe self-management support strategies for overcoming barriers to medication adherence.
Patient Adherence to Medications
Adherence
o Mosby’s Medical Dictionary defines adherence as “the process in which a person follows rules, guidelines, or standards, especially as patients follow a prescription and recommendations for a regimen of care”
Co-morbidity
Primary disease +
One or more diseases=
Co-morbidity
Self Management Support
o Demonstrating new skills
o Praise & Feedback
Self-Management
Chronic Care Model
Global Medication Adherence is 50%
WHO’s Five Dimensions of Adherence
1. Social & Economic
1. Social & Economic
o Community Support
1. Social & Economic
o Economic
1. Social & Economic
o Pictures– Use pictures when
giving instructions
o Read Back– Have the patient
read back the instructions
Prescription for Medication
1. Social & Economic
How to make an Economic Poster from a PowerPoint Slide
o Go to PowerPointo Use Graphics and
Make a Postero Take a thumb
drive or disc to a Print Shop and make a poster.
1. Social & EconomicUse Pictures When Teaching
2. Health Care System
o Provider-Patient Relationship
2. Health Care System
o Using two-way communications and asking open ended questions fosters encouragement.
o Shared Decision Making
2. Health Care System
3. Condition Related
o Chronic conditions, such as hypertension, that lack symptoms highly impact the level of adherence
o People’s belief about the benefits and risks of medications influence whether they abide by a regimen.
3. Condition Related
4. Therapy Related
o Therapy-related factors include the complexity of medication regimen and unpleasant side effects.
o Dosing several times a day may contribute to non-adherence.
4. Therapy Related
o Concern about medication side effects remains a powerful barrier.
4. Therapy Related
5. Patient Related
o Perception of need, medication effectiveness, and safety.
o Follow up Appointments
5. Patient Related
5. Patient Related
o Personalized education and counseling sessions delivered by telephone, intranet, or in person by trained personnel.
Conclusion
QUESTIONS AND DISCUSSION?
Referenceso Agency for Healthcare Research and Quality. (2002). Preventing
Disability in the Elderly with Chronic Disease. Retrieved May 15, 2010, from http://www.ahrq.gov/research/elderdis.htm.
o Chronic Care Model (2010). The Chronic Care Model. Retrieved June 15, 2010, from http://www.improvingchroniccare.org/index.php?p=The_Chronic_Care_Model&s=2
o Goldberg, E., Dekoven, M., Schabert, V., et al. (2009). Patient Medication Adherence: The Forgotten Aspect of Biologics. Biotechnology Healthcare, 39-44.
o Murray, M., Morrow, D., Weiner, M., et al. (2004). A Conceptual Framework to Study Medication Adherence in Older Adults. The American Journal of Geriatric Pharmacotherapy, 2(1), 36-43
References continued.
o Ruppar, T., Conn, V., & Russell, C. (2008). Medication Adherence Interventions for Older Adults: Literature Review. Research and Theory for Nursing Practice: An International Journal, 22(2) 114-147.
o Sherman, B., Frazee, S., Fabios, R., et al. (2009). Impact of Workplace Health Services on Adherence to Chronic Medications. The American Journal of Managed Care, 15(7), 53-59.
o Simpson, R. (2006). Challenges for Improving Medication Adherence. The Journal of the American Medical Association, 296(21), 2614-2616.
o World Health Organization. Adherence to Therapies: Evidence for Action. Geneva: World Health Organization, 2003
Contact Information
Susan Fleming, MN, RN, PhD [email protected]
Michele Wolfe, MN, [email protected]
